Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
- CNRS
- CEA
- Université Savoie Mont Blanc
- European Magnetism Association EMA
- Institut Pasteur
- UNIVERSITE PARIS CITE
- ASNR
- CNRS-ENS-UCBL
- IFP Energies nouvelles (IFPEN)
- Le Mans Université
- Nature Careers
- SORBONNE UNIVERSITE
- Université Bourgogne Europe
- Université de Caen Normandie
- Université de Reims Champagne Ardenne
- Université de Strasbourg
- 6 more »
- « less
-
Field
-
include: · building hierarchical causal graphs to account for the multi-scale structure of the experimental system, · detecting latent variables that may affect causal inference
-
, funded by the Bourgogne-Franche-Comté Region and co-funded by HARMI as part of the “Structuration de la Recherche en Bourgogne-Franche-Comté” program, through the TRANSBIO Graduate School. Planned timeline
-
information is available on the project website (still under construction) and on the YouTube channel. Planning research project : MIXAP-EU began in October 2024. We have already established partnerships and
-
-free solvents. Thermodynamic modeling studies will be used to determine the choice of solvents. The structural properties and magnetization dynamics will be measured by ferromagnetic resonance. The final
-
attention as a major regulatory marker controlling diverse aspects of RNA metabolism and function, including: alternative splicing, structure switching, export, miRNA maturation, stability, translation, m7G
-
increase in the number of strains that are multi-resistant to antifungal agents is leading to a growing incidence of two other species, C. glabrata and C. auris. Being a complex and dynamic structure
-
electronic structure on the ferroelectric properties. The chosen materials will be optimized by successive simulation, processing, and characterization iterations and integrated into scaled arrays to provide
-
, cellular, molecular, and structural approaches, focuses on generating and characterizing human monoclonal antibodies to viruses including HIV-1, Hepatitis E and B, as well as emerging pathogens such as SARS